Ex vivo drug screening and clustering of bladder cancers for pre-clinical treatment prediction.
Saved in:
| Title: | Ex vivo drug screening and clustering of bladder cancers for pre-clinical treatment prediction. |
|---|---|
| Authors: | Conroy S; Department of Urology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK., Gagg H; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK., Quayle LA; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK.; School of Computing and Digital Technologies, Sheffield Hallam University, Sheffield, UK., Adams JA; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK., Williams ST; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK.; Department of Oncology, Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Helleday T; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK.; Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden., Hussain SA; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK.; Department of Oncology, Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Griffin J; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK.; Department of Histopathology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Allen R; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK., Rantala JK; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK.; Misvik Biology Ltd, Karjakatu, Turku, Finland., Danson SJ; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK. s.danson@sheffield.ac.uk.; Department of Oncology, Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. s.danson@sheffield.ac.uk., Catto J; Department of Urology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. j.catto@sheffield.ac.uk.; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK. j.catto@sheffield.ac.uk., Wells G; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK. g.wells@sheffield.ac.uk. |
| Source: | Communications medicine [Commun Med (Lond)] 2026 May 14. Date of Electronic Publication: 2026 May 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918250414506676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2730-664X (Electronic) Linking ISSN: 2730664X NLM ISO Abbreviation: Commun Med (Lond) |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42135441 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Ex vivo drug screening and clustering of bladder cancers for pre-clinical treatment prediction. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Conroy+S%22">Conroy S</searchLink>; Department of Urology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Gagg+H%22">Gagg H</searchLink>; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Quayle+LA%22">Quayle LA</searchLink>; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK.; School of Computing and Digital Technologies, Sheffield Hallam University, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Adams+JA%22">Adams JA</searchLink>; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Williams+ST%22">Williams ST</searchLink>; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK.; Department of Oncology, Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Helleday+T%22">Helleday T</searchLink>; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK.; Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Hussain+SA%22">Hussain SA</searchLink>; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK.; Department of Oncology, Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Griffin+J%22">Griffin J</searchLink>; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK.; Department of Histopathology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Allen+R%22">Allen R</searchLink>; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Rantala+JK%22">Rantala JK</searchLink>; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK.; Misvik Biology Ltd, Karjakatu, Turku, Finland.<br /><searchLink fieldCode="AU" term="%22Danson+SJ%22">Danson SJ</searchLink>; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK. s.danson@sheffield.ac.uk.; Department of Oncology, Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. s.danson@sheffield.ac.uk.<br /><searchLink fieldCode="AU" term="%22Catto+J%22">Catto J</searchLink>; Department of Urology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. j.catto@sheffield.ac.uk.; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK. j.catto@sheffield.ac.uk.<br /><searchLink fieldCode="AU" term="%22Wells+G%22">Wells G</searchLink>; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK. g.wells@sheffield.ac.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918250414506676%22">Communications medicine</searchLink> [Commun Med (Lond)] 2026 May 14. <i>Date of Electronic Publication: </i>2026 May 14. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Portfolio%22">Nature Portfolio </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9918250414506676 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2730-664X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222730664X%22">2730664X </searchLink><i>NLM ISO Abbreviation: </i>Commun Med (Lond) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42135441 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s43856-026-01596-5 Languages: – Code: eng Text: English Titles: – TitleFull: Ex vivo drug screening and clustering of bladder cancers for pre-clinical treatment prediction. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Conroy S – PersonEntity: Name: NameFull: Gagg H – PersonEntity: Name: NameFull: Quayle LA – PersonEntity: Name: NameFull: Adams JA – PersonEntity: Name: NameFull: Williams ST – PersonEntity: Name: NameFull: Helleday T – PersonEntity: Name: NameFull: Hussain SA – PersonEntity: Name: NameFull: Griffin J – PersonEntity: Name: NameFull: Allen R – PersonEntity: Name: NameFull: Rantala JK – PersonEntity: Name: NameFull: Danson SJ – PersonEntity: Name: NameFull: Catto J – PersonEntity: Name: NameFull: Wells G IsPartOfRelationships: – BibEntity: Dates: – D: 14 M: 05 Text: 2026 May 14 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2730-664X Titles: – TitleFull: Communications medicine Type: main |
| ResultId | 1 |